Global Oncology, Cancer Drugs Market (Types, Treatments, Geography) - Global Industry Analysis, Growth, Trends, Opportunities, Size, Share and Forecast, 2013 - 2020 - Overview, Market Analysis, Global, Future Demand, Leaders, Company Profiles, Research Insights, Segmentation, Adoption, Sales, and Forecast The oncology drugs are used for the treatment of cancer. The oncology drug market is a segment in the pharmaceutical drug market. The rise in new cancer cases, which is 14.1million in 2012, is the major driving factor for the drugs market. The other factors driving the market are the demand for increase in treatment by aging population, and improvements in results of treatment. As the price varies from $5,000-$92,000 per month, the rising cost is the major restraint of the oncology market There are many new brands of drug available in the market that has good success rates, but the challenge faced is the accessibility of the drugs due to high cost. The cost correction of these branded drugs can provide a good opportunity for efficient and effective treatment. The key players profiled in this report are: Bayer healthcare pharmaceuticals, Celgene, Eli Lilly & Co, ImClone Systems Inc., GlaxoSmithKline, Merck & Co, Novartis Pharmaceuticals, Pfizer Inc., Roche and Sanofi. To Get Full Access Visit: http://www.bigmarketresearch.com/oncology-cancer-drugsmarket KEY BENEFITS: • The report provides in-depth analysis about types of drugs, treatment , types of cancer and geography in the oncology drugs market • The report evaluates the key factors that prove to be drivers and restraints for the market • The report discuses the oncology drugs market based on the various segments to forecast growth till 2020. • The report discuses the market factors in various geographic regions and also explores business opportunities
• The report analyzes the strategies applied by the profiled key players in the market KEY MARKET SEGMENT: GLOBAL MARKET BY, TYPE OF CANCER • Blood Cancer • Bone Cancer • Brain Cancer • Breast Cancer • Digestive/ Gastrointestinal Cancer • Endocrine Cancers • Eye Cancer • Genitourinary Cancers • Gynecologic Cancers • Head & Neck Cancers • Respiratory/Lung Cancers • Skin Cancers GLOBAL MARKET BY, TYPE OF CANCER TREATMENTS • Surgery • Chemotherapy • Radiation Therapy • Targeted Therapy • Immunotherapy (Biologic Therapy) • Hormonal Therapy • Hyperthermia • Stem Cell Transplant • Others GLOBAL MARKET BY, TYPE OF CANCER DRUGS • Rituxan • Herceptin • Avastin • Gleevec • Velcade • Sutent • Sprycel • Nexavar • Tasigna • Afinitor / Votubia • Xgeva • Yervoy • Erbitux
GLOBAL MARKET BY, GEOGRAPHY • North America • Europe • Asia pacific • RoW KEY AUDIENCE • Drug manufacturers • Hospital • Private and government research institutes • Academic institutes About Us: With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us: Sona Padman
5320 SW Macadam Avenue, Suite 100, Portland, OR 97239, United States. Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Fax: +1 (855) 550-5975 Email:sales@bigmarketresearch.com Web: http://www.bigmarketresearch.com